ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Renal function"

  • 2020 American Transplant Congress

    Transplant and Cardiovascular Outcomes in Renal Transplant Recipients with Different Pre-Transplant Cardiovascular Risk

    G. Hsu1, T. M. Sparkes1, B. N. Reed2, S. E. Gale1, B. R. Ravichandran1

    1University of Maryland Medical Center, Baltimore, MD, 2University of Maryland School of Pharmacy, Baltimore, MD

    *Purpose: Renal transplant patients have higher cardiovascular (CV) risk compared to their peers. Pre-transplant CV risk factors may be amplified post-transplant, but little is known…
  • 2019 American Transplant Congress

    Hephaistos Study Outcome on Renal Function after 12 Month Everolimus Plus Reduced Tacrolimus in De Novo Liver Transplant Recipients versus Standard Tacrolimus

    F. Braun1, P. Schemmer1, H. Schlitt1, A. Pascher1, C. Klein1, U. Neumann1, I. Kroeger2, P. Wimmer2, B. Nashan1

    1Study Group, Hephaistos, Germany, 2Novartis Pharma GmbH, Nuernberg, Germany

    *Purpose: The HEPHAISTOS study was designed to compare efficacy and safety of earlyuse of everolimus [EVR] combined with reduced tacrolimus [rTAC] versus Standard tacrolimus [TAC-C)…
  • 2019 American Transplant Congress

    Need of a New Formula to Estimate Creatinine Clearance in Immediate Post Kidney Transplant Period with Functioning Allograft

    A. B. Jain1, U. Farooq2, A. Brooks1, T. Dohi1, F. Butt1, Z. Kadry1

    1Surgery ( Transplant), Penn State Milton Hershey Medical Center, Hershey 17033, PA, 2Medicine( Neprhology), Penn State Milton Hershey Medical Center, Hershey, PA

    *Purpose: Introduction: Post kidney transplant (KTx), with functioning renal allograft, serum creatinine continues to decrease at a variable rate until it stabilizes after a few…
  • 2019 American Transplant Congress

    Consistent High Burden of Arteriosclerosis in Pediatric Kidney Transplant Recipients

    K. Ostendorf1, N. Memaran1, B. Borchert-Mörlins1, J. von der Born1, E. Bauer1, A. von Wick1, J. Oh2, M. J. Kemper3, R. Büscher4, B. M. Schmidt5, A. Melk1

    1Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hannover, Germany, 2Pediatric Nephrology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, 3Department of Pediatrics, Asklepios Klinik Nord - Heidberg, Hamburg, Germany, 4Pediatric Nephrology, University Hospital, Essen, Germany, 5Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany

    *Purpose: The second most common cause of death in pediatric kidney transplant (KT) recipients are cardiovascular (CV) diseases. We have previously shown that pulse wave…
  • 2019 American Transplant Congress

    Normothermic Ex-Vivo Kidney Perfusion Preservation Consistently Improves Extreme Marginal Graft Function Compared to Hypothermic Machine Perfusion

    P. Urbanellis1, M. Hamar1, I. Linares1, D. Kollmann1, S. Ganesh1, F. Oquendo1, M. Sharma1, R. John1, A. Ghanekar1, I. Mucsi1, D. Bagli2, A. Konvalinka1, L. Robinson3, M. Selzner1

    1Multi-Organ Transplantation Program, University Health Network, Toronto, ON, Canada, 2Division of Urology, The Hospital for Sick Children, Toronto, ON, Canada, 3Division of Nephrology, The Hospital for Sick Children, Toronto, ON, Canada

    *Purpose: Normothermic ex-vivo kidney perfusion (NEVKP) is an emerging technique for renal graft preservation. We investigated whether NEVKP promoted improved marginal graft function compared to…
  • 2019 American Transplant Congress

    First UK Experience of the Molecular Microscope (MMDX™) in the Kidney Transplant Clinic

    C. Lawrence1, S. Thiru2, A. Manoj1, S. Fluck1

    1Renal Medicine, The Lister Hospital, Stevenage, United Kingdom, 2Histopathology, Addenbrookes Hospital, Cambridge, United Kingdom

    *Purpose: Molecular diagnostic methods are now included in the Banff classification of kidney transplant pathology. Traditional histopathology may be limited by intra/inter pathologist variation. The…
  • 2019 American Transplant Congress

    Endovascular Repair Of Abdominal Aortic Aneurysms In Kidney Transplant Recipients

    S. Kwon1, D. Jung1, Y. Kim1, S. Park2, S. Yoon2

    1Department of Vascular and Transplant Surgery, The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Korea, Republic of, 2Department of Vascular and Transplant Surgery, The Catholic Universtiy of Korea, Seoul St. Mary's Hospital, Seoul, Korea, Republic of

    *Purpose: The possibility to diagnosis abdominal aortic aneurysm (AAA) in patients who underwent kidney transplantation (KT) is increasing. Immunosuppressive agents may effect on AAA progression.…
  • 2019 American Transplant Congress

    Long Term Renal Function Following Islet Transplantation in the Clinical Islet Transplantation Consortium

    L. G. Hunsicker1, T. L. Eggerman2, M. R. Rickels3, t. Clinical Islet Transplantation (CIT) Consortium4

    1Internal Medicine, U. Iowa, Iowa City, IA, 2NIDDK/NIH, Bethesda, MD, 3Internal Medicine, U. Pennsylvania, Philadelphia, PA, 4Internal Medicine, University of Iowa, Iowa City, IA

    *Purpose: Islet transplantation (IsletTp) is safe and effective treatment of Type 1 diabetes complicated by severe hypoglycemia (Diabetes Care 2016, 39:1230). But the requirement for…
  • 2019 American Transplant Congress

    GFR Outcomes for Recipients and Donors with IgA, FSGS, Alports and Thin Basement Membrane Disease: A Comparison of Living Related to Unrelated Donors

    D. Keys, S. Jackson, S. Riad, R. Spong, V. Vakil, A. Matas, P. Nachman

    University of Minnesota, Minneapolis, MN

    *Purpose: Prior studies have shown an increase rate of graft loss in patients that receive living donor kidney transplants from relatives in IgA, FSGS, and…
  • 2019 American Transplant Congress

    Early Everolimus Conversion For Renal Protection In Liver Transplantation: The Sooner The Better?

    M. Tomeczkowicz, N. Sulejmani, A. Jantz, B. Summers, T. Larson, R. Salgia

    Henry Ford Health System, Detroit, MI

    *Purpose: Calcineurin inhibitors (CNI) are the mainstay of immunosuppressive therapy in transplantation; however, a major side effect limiting CNI use is nephrotoxicity. Mammalian target of…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 27
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences